Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-20T05:19:50.790Z Has data issue: false hasContentIssue false

Stigma and ineffective legislation

Published online by Cambridge University Press:  02 January 2018

J. M. Clifford*
Affiliation:
St Bartholomew's Higher Training Scheme, South Forest Centre, 21 Thorne Close, Leytonstone, London E11 4HU
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © 2001 The Royal College of Psychiatrists 

Further to Haghighat (Reference Haghighat2001), I would like to point out that the impact of stigmatisation is what it was when Goffman was developing his thoughts on stigma.

The impact of the the Human Genome Project potentially reveals boundless information that is stigmatising to both individual and family, in terms of employment, education and insurance. Although Haghighat refers to legislation in this area to prevent such discrimination, existing law provides little confidence in these burgeoning areas. The UK Disability Discrimination Act 1995, specifically referring to physical or mental impairment, provides little but deficiencies in the setting of discrimination against a propensity of developing a disorder in the future. Discrimination against such individuals would not be deemed unlawful. Amendments regarding this issue were discussed in both Houses of Parliament but not implemented (Nuffield Council on Bioethics, 1998). In contrast, a number of states in the USA have prohibited the use of information about employees' genetic characteristics by employers (Reference YesleyYesley, 1997).

In insurance, clients who have undergone genetic tests will be required to inform insurance companies of these. Proposals to avoid the unfair use of genetic information by insurance companies were announced in November 1998. Such a scheme relies on a voluntary rather than legal framework between the Department of Trade and Industry and the Human Genetics Advisory Committee (Reference ClarkeClarke, 1995). This may do little to allay fears that an essentially profit-making business is being expected voluntarily to operate an ethical code of practice.

We may find that genetics provides a potential source of stigmatisation. As yet, the UK has few legal safeguards in place to protect individuals, who increasingly will have to manage this information carefully, rather as the ‘discreditable’ Goffman wrote of. Rather than legislation providing ‘institutional support’, the present situation serves only to propagate, in the public eye, a vision of a ‘genetic underclass’ (Reference ClarkeClarke, 1995). An underclass where the stigmatising scars are invisible but their devastating effects on individual freedom are all too apparent.

References

Clarke, A. (1995) Population screening for genetic susceptibility to disease. British Medical Journal, 311, 3538.Google Scholar
Haghighat, R. (2001) A unitary theory of stigmatisation. British Journal of Psychiatry, 178, 207215.CrossRefGoogle ScholarPubMed
Nuffield Council on Bioethics (1998) Mental Disorders and Genetics: The Ethical Context. London: Nuffield Council on Bioethics.Google Scholar
Yesley, M. (1997) Genetic privacy, discrimination and social policy. Microbial and Comparative Genomics, 2, 1935.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.